3B BlackBio Dx Ltd (3BBLACKBIO.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+21.4%

₹1,609.36

vs ₹1,326.00 price

Levered DCF

₹2,379.37

After debt service

Piotroski score

—

Altman Z-score

—

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	16.05×	30.14×	20.15×	12.03×	7.88×	1.87×	7.41×	10.9×
P/B	2.89×	5.35×	2.9×	1.82×	1.67×	1.61×	1.71×	2.57×
P/S	6.61×	14.89×	8.74×	5.03×	3.16×	0.94×	1.91×	2.49×
EV / EBITDA	14.8×	28.24×	19.62×	8.7×	6.17×	1.2×	5.25×	8.45×
Gross margin	54.2%	64.2%	59.7%	60.8%	55.1%	74.8%	41.4%	39.1%
Operating margin	36.4%	51.1%	43.1%	45.7%	45.2%	65.9%	30.4%	28.7%
Net margin	41.3%	49.4%	43.3%	41.9%	39.9%	50.2%	26.6%	22.5%
Current ratio	5.27×	7.11×	7.04×	8.05×	4.82×	2.76×	4.82×	3.08×
Debt / equity	0.01×	0×	0×	0.01×	0.02×	0.02×	0.11×	0.27×
Interest coverage	217.84×	454.59×	256.64×	142.55×	342.39×	654.18×	26.27×	14.42×
Dividend yield	0.4%	0.2%	0.3%	1.4%	6.1%	0.0%	3.2%	1.9%
Payout ratio	5.8%	5.4%	6.8%	17.1%	48.0%	0.0%	22.9%	20.5%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	18.1%	17.8%	14.4%	15.1%	21.0%	86.2%	23.9%	23.3%
Return on invested capital	11.8%	13.3%	10.0%	10.3%	15.3%	73.8%	17.3%	16.8%
Return on assets	15.5%	16.1%	12.9%	12.1%	16.8%	58.8%	17.1%	14.4%
Free cash flow yield	2.9%	3.0%	4.1%	7.4%	16.7%	44.9%	11.2%	4.1%
Earnings yield	6.2%	3.3%	5.0%	8.3%	12.6%	53.4%	14.0%	9.0%
Enterprise value	₹90.4M	₹166.5M	₹77.6M	₹30.9M	₹30.2M	₹24.5M	₹6.4M	₹8.8M
Net debt / EBITDA	-1.72×	-0.24×	-0.02×	-1.96×	-0.71×	-0.22×	-0.63×	0.39×
Cash conversion cycle (days)	193	210	105	271	175	68	267	318